Rencontrez nos orateurs experts

Dr Barry DEKEYSER

Anesthésiste, Belgique

“In my presentation, I will provide physicians with a systematic approach to diagnosing and treating common hair disorders, based on my extensive experience as a practitioner, trainer, and advisor in hair conditions. The role of trichoscopy in diagnostics will be highlighted. Several case studies will be presented, where patients were treated with platelet-rich plasma (PRP) and/or Er:YAG laser therapy. PRP and LASER are two modalities that have garnered significant interest.”

Dr Pierre ANDRE

Dermatologue, France

“I'm honored to lead the fillers complication session, surrounded by the best experts. We'll discuss how to avoid them and how to manage them. For anyone interested in aesthetic medicine, this session is fundamental, and I encourage you to attend. ”

Dr Smith ARAYASKUL

Dermatologue, Thaïlande

“Dear Esteemed Delegates, It is a great honor to welcome you to this year’s IMCAS World Congress. As an aesthetic physician and board-certified lifestyle medicine doctor, I am thrilled to join this prestigious event and share insights on non-invasive modalities for creating a higher social status perception look, a fascinating and growing demand in society. I look forward to learning, exchanging ideas, and connecting with you throughout the congress.May it be an enriching experience for us all! ”

Dr Patricia APT DRUCK

Dermatologue, Chili

“Dear colleagues, It is my honor to invite you to attend my sessions during the Congress in Paris, where we will delve into the latest advancements in laser technology for facial rejuvenation and effective melasma management. In these talks, I will share my clinical experiences, and the latest technological innovations that are transforming outcomes in aesthetic . Laser skin rejuvenation Thursday 30 Jan 2025 14:30-15:30 How to deal with Melasma Saturday 1 Feb 2025 10:30-12:30”

Dr Madiha Azmat RAO

Dermatologue, Pakistan

“Dear Colleagues, We are excited to invite you to join us at the upcoming IMCAS Paris conference, one of the world's premier events in aesthetic medicine. This year's edition promises to be an unforgettable experience, offering unparalleled opportunities for learning, networking, and growth. The most glamorous congress in the fashion hub of world ,Paris polishes the artist in me. Whenever I visit the museums I learn anatomy,expressions beauty and what not . Not to be missed. Dr Madiha Rao ”

Dr Jair Mauricio CERON BOHORQUEZ

Chirurgien, Allemagne

“Dear Colleagues, I’m thrilled to invite you to IMCAS World Congress 2025 in Paris, where science meets innovation in medical aesthetics. My topics: -Ultrasound Insights: Exploring the Superficial Temporal Fat Pad and Deep Interfacial Plane. -Circle of Safety: Ultrasound anatomy and complication management. -Ultrasound-Guided Botulinum Toxin Injections: Enhancing precision. -Experience Lab: Hands-on ultrasonography. Let´s become better injectors—see you in Paris! Mauricio Cerón, M.D.”

Dr Beatriz MOLINA

Médecin, Royaume-Uni

“I am thrilled to invite you to join me at the IMCAS World Congress 2025, the leading global event for dermatology, plastic surgery, and aesthetic science, taking place in PARIS. This well know conference is a unique opportunity to explore the cutting edge of our field. As part of the Congress, I am honored to be presenting on NAYCO Technology: where we will discuss its transformative potential in aesthetic medicine and the advancements it offers. Let’s collaborate, learn, and innovate together”

Dr Bruce REITH

Chirurgien Plasticien, Allemagne

“I'm speaking at IMCAS January 30th, 2025. 14.30 - 15.30 January 31st, 2025”

Dr Rachita DHURAT

Dermatologue, Inde

“Cetirizine has demonstrated inhibitory effects on prostaglandin D2 synthesis, a molecule implicated in the pathogenesis of hair follicle miniaturization in AGA. In our case series there was an increase in the hair count as compared to the baseline in 9/9 subjects post 16 weeks of therapy. The mean hair count at week 0 was 139.56 (SE of mean of 13.92) and at 16 weeks was 163.44 (SE of mean of 15.52). Cetirizine presents a potential addition to the therapeutic armamentarium for AGA.”